Lomustine and Temozolomide in Combination with Radiotherapy New First-Line Treatment Option for Patients with MGMT Promoter methylated Glioblastoma

被引：0
|
作者：
Seidel, Clemens [1 ]
Kortmann, Rolf-Dieter [1 ]
机构：
[1] Univ Klin Radioonkol & Strahlentherapie, Stephanstr 9a, D-04103 Leipzig, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2019年 / 195卷 / 09期
关键词：
NEWLY-DIAGNOSED GLIOBLASTOMA; BEVACIZUMAB; TRIAL;
D O I：
10.1007/s00066-019-01487-w
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：855 / 856
页数：2
相关论文
共 50 条
  • [1] Combination Therapy of Lomustine and Temozolomide in Patients with newly diagnosed Glioblastoma with methylated MGMT Promotor
    Lenzen, Julia
    Feldmann, H. J.
    ONKOLOGE, 2019, 25 (12): : 1118 - 1120
  • [2] FIRST MULTICENTRIC REAL-LIFE EXPERIENCE WITH THE COMBINATION OF LOMUSTINE AND TEMOZOLOMIDE IN NEWLY DIAGNOSED MGMT PROMOTER METHYLATED IDH WILDTYPE GLIOBLASTOMA
    Lazaridis, L.
    Schmidt, T.
    Agkatsev, S.
    Blau, T.
    Spille, D.
    Heider, S.
    Schulz, T.
    Bumes, E.
    Oster, C.
    Feldheim, J.
    Stummer, W.
    Kessler, A.
    Seidel, C.
    Hau, P.
    Sure, U.
    Keyvani, K.
    Herrlinger, U.
    Kleinschnitz, C.
    Stuschke, M.
    Herrmann, K.
    Deuschl, C.
    Hattingen, E.
    Scheffler, B.
    Kebir, S.
    Glas, M.
    NEURO-ONCOLOGY, 2022, 24
  • [3] Concurrent Radiotherapy and Temozolomide Followed by Temozolomide and Sorafenib in the First-Line Treatment of Patients With Glioblastoma Multiforme
    Hainsworth, John D.
    Ervin, Thomas
    Friedman, Elke
    Priego, Victor
    Murphy, Patrick B.
    Clark, Bobby L.
    Lamar, Ruth E.
    CANCER, 2010, 116 (15) : 3663 - 3669
  • [4] Lomustine and temozolomide for newly diagnosed glioblastoma with methylated MGMT promoter: Lessons from the CeTeG/NOA-09 trial
    Tremont-Lukats, Ivo W.
    Teh, Bin S.
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S589 - S591
  • [5] Lomustin und Temozolomid in Kombination mit BestrahlungNeue Option in der Erstlinientherapie bei Patienten mit Glioblastom mit methyliertem MGMT-PromotorLomustine and temozolomide in combination with radiotherapyNew treatment option for patients with MGMT promoter methylated Glioblastoma
    Clemens Seidel
    Rolf-Dieter Kortmann
    Strahlentherapie und Onkologie, 2019, 195 (9) : 855 - 856
  • [6] COMBINED TREATMENT WITH HYPOFRACTIONATED RADIOTHERAPY AND TEMOZOLOMIDE BENEFITS OVER SINGLE TREATMENT IN ELDERLY PATIENTS WITH METHYLATED BUT NOT UNMETHYLATED MGMT GLIOBLASTOMA
    Nagane, Motoo
    Yamagishi, Yuki
    Kobayashi, Keiichi
    Saito, Kuniaki
    Shimada, Daisuke
    Kume, Satoshi
    Iijima, Shohei
    Sasaki, Nobuyoshi
    Shiokawa, Yoshiaki
    NEURO-ONCOLOGY, 2017, 19 : 11 - 11
  • [7] Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine
    Wenger, Katharina J.
    Wagner, Marlies
    You, Se-Jong
    Franz, Kea
    Harter, Patrick N.
    Burger, Michael C.
    Voss, Martin
    Ronellenfitsch, Michael W.
    Fokas, Emmanouil
    Steinbach, Joachim P.
    Baehr, Oliver
    ONCOLOGY LETTERS, 2017, 14 (01) : 1141 - 1146
  • [8] FIRST MULTICENTRIC REAL-LIFE EXPERIENCE WITH THE COMBINATION OF CCNU AND TEMOZOLOMIDE IN NEWLY DIAGNOSED MGMT PROMOTER METHYLATED IDH WILDTYPE GLIOBLASTOMA
    Lazaridis, Lazaros
    Bumes, Elisabeth
    Spille, Dorothee Cacilia
    Schulz, Tim
    Heider, Sina
    Agkatsev, Sarina
    Schmidt, Teresa
    Blau, Tobias
    Oster, Christoph
    Feldheim, Jonas
    Stummer, Walter
    Kessler, Almuth Friederike
    Seidel, Clemens
    Grauer, Oliver
    Hau, Peter
    Sure, Ulrich
    Keyvani, Kathy
    Herrlinger, Ulrich
    Kleinschnitz, Christoph
    Stuschke, Martin
    Herrmann, Ken
    Deuschl, Cornelius
    Breuer, Stella
    Hattingen, Elke
    Scheffler, Bjoern
    Kebir, Sied
    Glas, Martin
    NEURO-ONCOLOGY, 2022, 24 : 74 - 74
  • [9] First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastoma
    Lazaridis, Lazaros
    Bumes, Elisabeth
    Spille, Dorothee Caecilia
    Schulz, Tim
    Heider, Sina
    Agkatsev, Sarina
    Schmidt, Teresa
    Blau, Tobias
    Oster, Christoph
    Feldheim, Jonas
    Stummer, Walter
    Kessler, Almuth Friederike
    Seidel, Clemens
    Grauer, Oliver
    Hau, Peter
    Sure, Ulrich
    Keyvani, Kathy
    Herrlinger, Ulrich
    Kleinschnitz, Christoph
    Stuschke, Martin
    Herrmann, Ken
    Deuschl, Cornelius
    Breuer, Stella
    Hattingen, Elke
    Scheffler, Bjoern
    Kebir, Sied
    Glas, Martin
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [10] Progressive multifocal leukoencephalopathy after first-line radiotherapy and temozolomide for glioblastoma
    Picca, Alberto
    Desjardins, Clement
    Bihan, Kevin
    Weiss, Nicolas
    Guihot, Amelie
    Nichelli, Lucia
    Feuvret, Loic
    Pourcher, Valerie
    Touat, Mehdi
    Dehais, Caroline
    NEURO-ONCOLOGY, 2022, 24 (03) : 497 - 498
12345